\documentclass{article}

\usepackage{hyperref}
\usepackage{xcolor}
\usepackage{graphicx}
\usepackage{array} % fixed with table cells

\title{Biodivne Boolean Models: A Comprehensive Logical Modelling Benchmark}
\author{Samuel Pastva}
\date{}

% Fixed width table columns
\newcolumntype{L}[1]{>{\raggedright\let\newline\\\arraybackslash\hspace{0pt}}m{#1}}
\newcolumntype{C}[1]{>{\centering\let\newline\\\arraybackslash\hspace{0pt}}m{#1}}
\newcolumntype{R}[1]{>{\raggedleft\let\newline\\\arraybackslash\hspace{0pt}}m{#1}}

\begin{document}
\maketitle

\begin{abstract}
	Recent years have seen emergence of a wide variety of powerful tools for computational analysis of logical models represented as Boolean networks. However, assessment of validity, efficiency and scalability of such tools requires a comprehensive benchmark set of Boolean networks that can be used to obtain comparable results for different tools.
	
	At the moment, this need is largely served using databases of biological models such as CellCollective or GINsim database. However, these databases are more focused on human curated, biological aspects of the networks and are therefore limited in scope. Furthermore, the models in these databases are not available as a single dataset and often have to be manually obtained one by one.
	
	Here, we introduce a comprehensive benchmark dataset that has been created by surveying the aforementioned databases, as well as a large body of other literature to obtain as many biologically motivated Boolean networks as possible. To make the dataset useful to a wide range of tool maintainers, we provide the models in different machine-readable formats and ensure all models are valid and consistent using an automated validation procedure. At the moment, the dataset comprises 145 networks.
\end{abstract}

\section{Introduction}

Logical models provide a very useful and simple framework for description of complex biological processes. The most common mechanism for describing executable logical models are Boolean networks. In recent years, we have seen a rapid development of new tools and algorithms for analysis of large Boolean networks. However, in many instances, it is hard to assess usefulness and scalability of such tools due to a lack of commonly recognised ``benchmark dataset'' of networks on which the tools can be compared.

This purpose is often served by models obtained from databases maintained by the authors of some of the larger modelling tools, such as CellCollective~\cite{cell-collective} or GINsim~\cite{ginsim}. However, these models are often hard to obtain in bulk and have to be downloaded one by one. Additionally, authors often modify the models slightly, or assume non-standard values of inputs which prevents comparisons. Finally, these databases are far from comprehensive, so a wide range of models is often omitted.

As a result, most papers develop an ad hoc benchmark set that is often partially proprietary and hard or impossible to replicate and compare to. Here, we propose a standardized comprehensive benchmark set that can be used for this purpose instead. To make the benchmark set as user friendly as possible, we provide the following benefits compared to existing solutions:

\begin{itemize}
	\item The dataset is open source and available on Github, so that anyone can propose new additions or modifications. Each tracked model is (primarily) referred to using a unique ID as opposed to name or citation. However, we also keep track of the original source (publication) where the model first appeared.
	
	\item Every model is provided in three formats that can be consumed by different tools or easily parsed by a new tool. Namely, we consider \texttt{bnet}, as popularised by PyBoolNet~\cite{pyboolnet}, \texttt{aeon} format as used in AEON~\cite{aeon}, and the universal SBML-qual~\cite{sbml-qual} format.
	
	\item If the model contains inputs (constants), aside from the model as published by the authors, we also generate two variants with all inputs fixed to \texttt{true} and \texttt{false}, and a variant where the values of all inputs are unspecified.
	
	\item For each model format and variant, we provide a single bundle with all available models that can be easily used for batch processing.
	
	\item We provide an automated procedure to check the validity and integrity of all included models, as well as generate different model bundles. This minimises possible user errors when adding new models.
\end{itemize}

This document then serves as a cumulative report of all the models included in the dataset and the sources of these models.

\section{Models}

\begin{center}
	\begin{tabular}{ | C{16pt} | C{144pt} | C{25pt} | C{25pt} | C{25pt} | C{35pt} | }
		\hline
		ID & Name & Vars. & Inps. & Regs. & Source \\ \hline
		001 & \texttt{SIGNALING IN MACROPHAGE ACTIVATION} & 302 & 19 & 533 & \cite{bbm-001, cell-collective} \\ \hline
		002 & \texttt{SIGNAL TRANSDUCTION IN~FIBROBLASTS} & 130 & 9 & 557 & \cite{bbm-002, cell-collective} \\ \hline
		003 & \texttt{MAMMALIAN CELL CYCLE} & 19 & 1 & 51 & \cite{bbm-003, cell-collective} \\ \hline
		004 & \texttt{ERBB RECEPTOR SIGNALING} & 225 & 22 & 1100 & \cite{bbm-004, cell-collective}  \\ \hline
		005 & \texttt{FA/BRCA PATHWAY} & 28 & 0 & 123 & \cite{bbm-005, cell-collective} \\ \hline
		006 & \texttt{HGF SIGNALING IN~KERATINOCYTES} & 62 & 6 & 103 & \cite{bbm-006, cell-collective} \\ \hline
		007 & \texttt{CORTICAL AREA DEVELOPMENT} & 5 & 0 & 14 & \cite{bbm-007, cell-collective} \\ \hline
		008 & \texttt{DEATH RECEPTOR SIGNALING} & 25 & 3 & 45 & \cite{bbm-008-150, cell-collective} \\ \hline
		009 & \texttt{YEAST APOPTOSIS} & 60 & 13 & 114 & \cite{bbm-009, cell-collective} \\ \hline
		010 & \texttt{CARDIAC-DEVELOPMENT} & 13 & 2 & 37 & \cite{bbm-010, cell-collective} \\ \hline
		011 & \texttt{GUARD CELL ABSCISIC ACID~SIGNALING} & 40 & 4 & 78 & \cite{bbm-011, cell-collective} \\ \hline		
		012 &Â \texttt{T-CELL RECEPTOR SIGNALING} & 94 & 7 & 158 & \cite{bbm-012, cell-collective} \\ \hline
		013 & \texttt{CHOLESTEROL REGULATORY~PATHWAY} & 32 & 2 & 41 & \cite{bbm-013, cell-collective} \\ \hline
		014 & \texttt{T-LGL SURVIVAL NETWORK 2008} & 54 & 7 & 193 & \cite{bbm-014, cell-collective} \\ \hline
		015 & \texttt{NEUROTRANSMITTER SIGNALING~PATHWAY} & 14 & 2 & 20 & \cite{bbm-015, cell-collective} \\ \hline
		016 & \texttt{IL-1 SIGNALING} & 104 & 14 & 218 & \cite{bbm-016-019, cell-collective} \\ \hline
		017 & \texttt{DIFFERENTIATION OF T-LYMPHOCYTES}  & 41 & 9 & 97 & \cite{bbm-017, cell-collective} \\ \hline
		018 & \texttt{EGFR-ERBB SIGNALING} & 76 & 28 & 226 & \cite{bbm-018, cell-collective} \\ \hline
		019 & \texttt{IL-6 SIGNALING} & 71 & 15 & 149 & \cite{bbm-016-019, cell-collective} \\ \hline
		020 & \texttt{APOPTOSIS NETWORK} & 39 & 2 & 73 & \cite{bbm-020, cell-collective} \\ \hline
		021 & \texttt{BODY SEGMENTATION IN DROSOPHILA 2013} & 14 & 3 & 29 & \cite{bbm-021, cell-collective} \\ \hline
		022 & \texttt{B-CELL DIFFERENTIATION} & 17 & 5 & 39 & \cite{bbm-022, cell-collective} \\ \hline
		023 & \texttt{MAMMALIAN CELL CYCLE 2006} & 9 & 1 & 34 & \cite{bbm-023, cell-collective} \\ \hline
		024 & \texttt{BUDDING YEAST CELL CYCLE} & 16 & 4 & 42 & \cite{bbm-024, cell-collective} \\ \hline
		025 & \texttt{T-LGL SURVIVAL NETWORK 2011} & 54 & 6 & 195 & \cite{bbm-025-074, cell-collective} \\ \hline
		026 & \texttt{BUDDING YEAST CELL~CYCLE~2009} & 18 & 0 & 59 & \cite{bbm-026, cell-collective} \\ \hline
		027 & \texttt{WG PATHWAY OF DROSOPHILA} & 12 & 14 & 29 & \cite{bbm-drosophila, cell-collective} \\ \hline
		028 & \texttt{VEGF PATHWAY OF DROSOPHILA} & 10 & 8 & 18 & \cite{bbm-drosophila, cell-collective} \\ \hline
		029 & \texttt{TOLL PATHWAY OF DROSOPHILA} & 9 & 2 & 11 & \cite{bbm-drosophila, cell-collective} \\ \hline
		030 & \texttt{SPZ NETWORK OF DROSOPHILA} & 18 & 6 & 28 & \cite{bbm-drosophila, cell-collective} \\ \hline
	\end{tabular}	

	\begin{tabular}{ | C{16pt} | C{149pt} | C{25pt} | C{25pt} | C{25pt} | C{35pt} | }
		\hline
		ID & Name & Vars. & Inps. & Regs. & Source \\ 
		\hline
		031 & \texttt{CELL CYCLE TRANSCRIPTION} & 9 & 0 & 19 & \cite{bbm-031, cell-collective} \\ 
		\hline
		032 & \texttt{T-CELL SIGNALLING 2006} & 37 & 3 & 53 & \cite{bbm-032, cell-collective} \\ 
		\hline
		033 & \texttt{BT474 BREAST CELL LINE~LONG~TERM} & 19 & 5 & 68 & \cite{bbm-breast-cell-line, cell-collective} \\ 
		\hline
		034 & \texttt{HCC1954 BREAST CELL LINE~LONG~TERM} & 19 & 4 & 68 & \cite{bbm-breast-cell-line, cell-collective} \\ 
		\hline
		035 & \texttt{BT474 BREAST CELL LINE~SHORT~TERM} & 11 & 5 & 46 & \cite{bbm-breast-cell-line, cell-collective} \\ 
		\hline
		036 & \texttt{HCC1954 BREAST CELL LINE~SHORT~TERM} & 11 & 5 & 46 & \cite{bbm-breast-cell-line, cell-collective} \\ 
		\hline
		037 & \texttt{SKBR3 BREAST CELL LINE~SHORT~TERM} & 11 & 5 & 41 & \cite{bbm-breast-cell-line, cell-collective} \\ 
		\hline
		038 & \texttt{SKBR3 BREAST CELL LINE~LONG~TERM} & 21 & 4 & 81 & \cite{bbm-breast-cell-line, cell-collective} \\ 
		\hline
		039 & \texttt{HIV-1 INTERACTIONS WITH T-CELL SIGNALING} & 124 & 14 & 368 & \cite{bbm-039, cell-collective} \\ 
		\hline
		040 & \texttt{T-CELL DIFFERENTIATION} & 19 & 4 & 34 & \cite{bbm-040, cell-collective} \\ 
		\hline
		041 & \texttt{INFLUENZA VIRUS REPLICATION~CYCLE} & 120 & 11 & 302 & \cite{bbm-041, cell-collective} \\ 
		\hline
		042 & \texttt{TOL REGULATORY NETWORK} & 14 & 10 & 48 & \cite{bbm-042, cell-collective} \\ 
		\hline
		043 & \texttt{BORDETELLA BRONCHISEPTICA} & 33 & 0 & 79 & \cite{bbm-043-044-046, cell-collective} \\ 
		\hline
		044 & \texttt{TRICHOSTRONGYLUS RETORTAEFORMIS} & 25 & 1 & 58 & \cite{bbm-043-044-046, cell-collective} \\ 
		\hline
		045 & \texttt{HH PATHWAY OF DROSOPHILA} & 11 & 13 & 32 & \cite{bbm-drosophila, cell-collective} \\ 
		\hline
		046 & \texttt{B~BRONCHISEPTICA AND T~RETORTAEFORMIS} & 52 & 1 & 135 & \cite{bbm-043-044-046, cell-collective} \\ 
		\hline
		047 & \texttt{FGF PATHWAY OF DROSOPHILA} & 14 & 9 & 24 & \cite{bbm-drosophila, cell-collective} \\ 
		\hline
		048 & \texttt{GLUCOSE REPRESSION SIGNALING~2009} & 55 & 18 & 97 & \cite{bbm-048, cell-collective} \\
		\hline
		049 & \texttt{OXIDATIVE STRESS PATHWAY} & 18 & 1 & 32 & \cite{bbm-049, cell-collective} \\
		\hline
		050 & \texttt{CD4 T-CELL SIGNALING} & 154 & 34 & 351 & \cite{bbm-050, cell-collective} \\
		\hline
		051 & \texttt{COLITIS ASSOCIATED COLON~CANCER} & 69 & 1 & 153 & \cite{bbm-051, cell-collective} \\
		\hline
		052 & \texttt{SEPTATION INITIATION NETWORK} & 23 & 8 & 50 & \cite{bbm-052, cell-collective} \\
		\hline
		053 & \texttt{PREDICTING VARIABILITIES IN~CARDIAC GENE} & 13 & 2 & 37 & \cite{bbm-053, cell-collective} \\ 
		\hline
		054 & \texttt{PC12 CELL DIFFERENTIATION} & 61 & 1 & 108 & \cite{bbm-054, cell-collective} \\
		\hline
		055 & \texttt{HUMAN GONADAL SEX DETERMINATION} & 19 & 0 & 79 & \cite{bbm-055, cell-collective} \\
		\hline
		056 & \texttt{IGVH MUTATIONS IN~LYMPHOCYTIC LEUKEMIA} & 66 & 25 & 125 & \cite{bbm-056, cell-collective} \\
		\hline
	\end{tabular}

	\begin{tabular}{ | C{16pt} | C{149pt} | C{25pt} | C{25pt} | C{25pt} | C{35pt} | }
		\hline
		ID & Name & Vars. & Inps. & Regs. & Source \\ 
		\hline
		057 & \texttt{FANCONI ANEMIA AND CHECKPOINT RECOVERY} & 15 & 0 & 66 & \cite{bbm-057, cell-collective} \\
		\hline
		058 & \texttt{ARABIDOPSIS THALIANA CELL~CYCLE} & 14 & 0 & 66 & \cite{bbm-058, cell-collective} \\
		\hline
		059 & \texttt{BORTEZOMIB RESPONSES IN~MYELOMA CELLS} & 62 & 5 & 131 & \cite{bbm-059, cell-collective} \\
		\hline
		060 & \texttt{STOMATAL OPENING} & 44 & 5 & 167 & \cite{bbm-060, cell-collective} \\
		\hline
		061 & \texttt{TUMOR MICROENVIRONMENT IN LYMPHOBLASTIC LEUKAEMIA} & 24 & 2 & 79 & \cite{bbm-061, cell-collective} \\ 
		\hline
		062 & \texttt{CD4 T-CELL DIFFERENTIATION AND PLASTICITY} & 12 & 6 & 78 & \cite{bbm-062, cell-collective} \\ 
		\hline
		063 & \texttt{LAC OPERON} & 10 & 3 & 22 & \cite{bbm-063, cell-collective} \\ 
		\hline
		064 & \texttt{METABOLIC INTERACTIONS IN GUT MICROBIOME} & 8 & 4 & 27 & \cite{bbm-064, cell-collective} \\ 
		\hline
		065 & \texttt{TUMOUR CELL INVASION AND MIGRATION} & 30 & 2 & 156 & \cite{bbm-065-086, cell-collective} \\ 
		\hline
		066 & \texttt{CD4 T-CELL DIFFERENTIATION} & 29 & 9 & 96 & \cite{cell-collective} \\ 
		\hline
		067 & \texttt{REGULATION OF L-ARABINOSE OPERON} & 9 & 4 & 18 & \cite{bbm-067, cell-collective} \\ 
		\hline
		068 & \texttt{AURORA KINASE-A IN NEUROBLASTOMA} & 19 & 4 & 43 & \cite{bbm-068, cell-collective} \\ 
		\hline
		069 & \texttt{IRON ACQUISITION AND STRESS RESPONSE} & 20 & 2 & 38 & \cite{bbm-069, cell-collective} \\ 
		\hline
		070 & \texttt{MAPK CANCER CELL FATE} & 49 & 4 & 104 & \cite{bbm-070-089-090-091, cell-collective} \\ 
		\hline
		071 & \texttt{CASTRATION RESISTANT PROSTATE CANCER} & 28 & 14 & 51 & \cite{bbm-071, cell-collective} \\ 
		\hline
		072 & \texttt{LYMPHOPOIESIS REGULATORY NETWORK} & 67 & 14 & 160 & \cite{bbm-072, cell-collective} \\ 
		\hline
		073 & \texttt{LYMPHOID AND MYELOID CELL SPECIFICATION} & 31 & 2 & 94 & \cite{bbm-073-177, cell-collective} \\ 
		\hline
		074 & \texttt{T-LGL SURVIVAL NETWORK 2011 REDUCED} & 18 & 0 & 43 & \cite{bbm-025-074, cell-collective} \\ 
		\hline
		075 & \texttt{INFLAMMATORY BOWEL DISEASE} & 47 & 0 & 287 & \cite{bbm-075, cell-collective} \\ 
		\hline
		076 & \texttt{SENESCENCE ASSOCIATED SECRETORY PHENOTYPE} & 49 & 2 & 96 & \cite{bbm-076, cell-collective} \\ 
		\hline
		077 & \texttt{SIGNALLING PATHWAY FOR BUTANOL PRODUCTION} & 53 & 13 & 139 & \cite{bbm-077, cell-collective} \\ 
		\hline
		078 & \texttt{IMMUNE SYSTEM} & 151 & 13 & 506 & \cite{cell-collective} \\ 
		\hline
		079 & \texttt{----} & -- & -- & -- & -- \\ 
		\hline
		080 & \texttt{TCR SIGNALING 2018} & 95 & 15 & 212 & \cite{bbm-080-081-082, ginsim} \\ 
		\hline
		081 & \texttt{TLR5 SIGNALING 2018} & 40 & 2 & 68 & \cite{bbm-080-081-082, ginsim} \\
		\hline
		082 & \texttt{TCR-TLR5 SIGNALING 2018} & 112 & 16 & 257 & \cite{bbm-080-081-082, ginsim} \\
		\hline
		083 & \texttt{SIGNALING IN PROSTATE CANCER} & 122 & 11 & 420 & \cite{bbm-083, ginsim} \\
		\hline
		084 & \texttt{----} & -- & -- & -- & -- \\
		\hline
		085 & \texttt{----} & -- & -- & -- & -- \\
		\hline
	\end{tabular}

	\begin{tabular}{ | C{16pt} | C{149pt} | C{25pt} | C{25pt} | C{25pt} | C{35pt} | }
		\hline
		ID & Name & Vars. & Inps. & Regs. & Source \\ 
		\hline
		086 & \texttt{TUMOUR CELL INVASION AND MIGRATION REDUCED} & 18 & 2 & 88 & \cite{bbm-065-086, ginsim} \\
		\hline
		087 & \texttt{----} & -- & -- & -- & -- \\
		\hline
		088 & \texttt{MIR-9 NEUROGENESIS} & 6 & 0 & 11 & \cite{bbm-088, ginsim} \\
		\hline
		089 & \texttt{MAPK REDUCED 1} & 13 & 4 & 78 & \cite{bbm-070-089-090-091, ginsim} \\
		\hline
		090 & \texttt{MAPK REDUCED 2} & 14 & 4 & 60 & \cite{bbm-070-089-090-091, ginsim} \\
		\hline
		091 & \texttt{MAPK REDUCED 3} & 12 & 4 & 58 & \cite{bbm-070-089-090-091, ginsim} \\
		\hline
		092 & \texttt{----} & -- & -- & -- & -- \\
		\hline
		093 & \texttt{IMMUNE CHECKPOINT INHIBITORS} & 51 & 15 & 128 & \cite{bbm-093, ginsim} \\
		\hline
		094 & \texttt{----} & -- & -- & -- & -- \\
		\hline
		095 & \texttt{FISSION YEAST 2008} & 9 & 1 & 27 & \cite{bbm-095, ginsim} \\
		\hline
		096 & \texttt{ERBB REGULATED G1-S TRANSITION} & 19 & 1 & 48 & \cite{bbm-096, ginsim} \\
		\hline
		097 & \texttt{DROSOPHILA WINGS AP} & 8 & 2 & 14 & \cite{bbm-097, ginsim} \\
		\hline
		098 & \texttt{----} & -- & -- & -- & -- \\
		\hline
		099 & \texttt{----} & -- & -- & -- & -- \\
		\hline
		100 & \texttt{----} & -- & -- & -- & -- \\
		\hline
		101 & \texttt{----} & -- & -- & -- & -- \\
		\hline
		102 & \texttt{----} & -- & -- & -- & -- \\
		\hline
		103 & \texttt{----} & -- & -- & -- & -- \\
		\hline
		104 & \texttt{DROSOPHILA CELL CYCLE} & 11 & 3 & 42 & \cite{bbm-104, ginsim} \\
		\hline
		105 & \texttt{----} & -- & -- & -- & -- \\
		\hline
		106 & \texttt{----} & -- & -- & -- & -- \\
		\hline
		107 & \texttt{----} & -- & -- & -- & -- \\
		\hline
		108 & \texttt{GEROCONVERSION} & 23 & 2 & 67 & \cite{bbm-108, ginsim} \\
		\hline
		109 & \texttt{ASYMMETRIC CELL DIVISION A} & 5 & 0 & 15 & \cite{bbm-109-110, ginsim} \\
		\hline
		110 & \texttt{ASYMMETRIC CELL DIVISION B} & 9 & 0 & 12 & \cite{bbm-109-110, ginsim} \\
		\hline
		111 & \texttt{APOPTOSIS} & 18 & 15 & 40 & \cite{bbm-covid-disease-map} \\
		\hline
		112 & \texttt{COAGULATION PATHWAY} & 85 & 27 & 195 & \cite{bbm-covid-disease-map} \\
		\hline
		113 & \texttt{ER STRESS} & 107 & 75 & 266 & \cite{bbm-covid-disease-map} \\
		\hline
		114 & \texttt{ETC} & 46 & 38 & 154 & \cite{bbm-covid-disease-map} \\
		\hline
		115 & \texttt{E PROTEIN} & 17 & 18 & 40 & \cite{bbm-covid-disease-map} \\
		\hline
		116 & \texttt{HMOX1 PATHWAY} & 89 & 55 & 228 & \cite{bbm-covid-disease-map} \\
		\hline
		117 & \texttt{IFN LAMBDA} & 28 & 19 & 52 & \cite{bbm-covid-disease-map} \\
		\hline
		118 & \texttt{INTERFERON 1} & 66 & 55 & 190 & \cite{bbm-covid-disease-map} \\
		\hline
		119 & \texttt{JNK PATHWAY} & 13 & 6 & 21 & \cite{bbm-covid-disease-map} \\
		\hline
		120 & \texttt{KYNURENINE PATHWAY} & 78 & 72 & 304 & \cite{bbm-covid-disease-map} \\
		\hline
		121 & \texttt{NLRP3 ACTIVATION} & 39 & 18 & 91 & \cite{bbm-covid-disease-map} \\
		\hline
		122 & \texttt{NSP14} & 74 & 94 & 558 & \cite{bbm-covid-disease-map} \\
		\hline
		123 & \texttt{NSP4 NSP6} & 43 & 17 & 62 & \cite{bbm-covid-disease-map} \\
		\hline
		124 & \texttt{NSP9 PROTEIN} & 119 & 133 & 257 & \cite{bbm-covid-disease-map} \\
		\hline
		125 & \texttt{ORF10 CUL2 PATHWAY} & 34 & 17 & 92 & \cite{bbm-covid-disease-map} \\
		\hline
 	\end{tabular}	
 
 	\begin{tabular}{ | C{16pt} | C{149pt} | C{25pt} | C{25pt} | C{25pt} | C{35pt} | }
 		\hline
 		ID & Name & Vars. & Inps. & Regs. & Source \\ 
 		\hline
		126 & \texttt{ORF3A} & 24 & 18 & 56 & \cite{bbm-covid-disease-map} \\
 		\hline
 		127 & \texttt{PAMP SIGNALING} & 44 & 35 & 109 & \cite{bbm-covid-disease-map} \\
 		\hline
 		128 & \texttt{PYRIMIDINE DEPRIVATION} & 56 & 34 & 131 & \cite{bbm-covid-disease-map} \\
 		\hline
 		129 & \texttt{RTC AND TRANSCRIPTION} & 33 & 1 & 40 & \cite{bbm-covid-disease-map} \\
 		\hline
 		130 & \texttt{RENIN ANGIOTENSIN} & 43 & 34 & 130 & \cite{bbm-covid-disease-map} \\
 		\hline
 		131 & \texttt{TGFB PATHWAY} & 7 & 14 & 24 & \cite{bbm-covid-disease-map} \\
 		\hline
 		132 & \texttt{VIRUS REPLICATION CYCLE} & 129 & 19 & 268 & \cite{bbm-covid-disease-map} \\
 		\hline
 		133 & \texttt{ROOT STEM CELL 2010} & 8 & 2 & 16 & \cite{bbm-133, biomodels} \\
 		\hline
		134 & \texttt{----} & -- & -- & -- & -- \\
 		\hline
 		135 & \texttt{SIGNAL TRANSDUCTION} & 28 & 2 & 33 & \cite{bbm-135, biomodels} \\
 		\hline
 		136 & \texttt{EGF TNF ALPHA SIGNALLING PATHWAY} & 26 & 2 & 31 & \cite{sbml-qual, biomodels} \\
 		\hline
 		137 & \texttt{SIGNALLING IN LIVER CANCER} & 71 & 11 & 118 & \cite{bbm-137, biomodels} \\
 		\hline
 		138 & \texttt{----} & -- & -- & -- & -- \\
 		\hline
 		139 & \texttt{ACUTE RESPONSES DURING HYPERINSULINEMIA} & 10 & 9 & 64 & \cite{bbm-139, biomodels} \\
 		\hline
		140 & \texttt{----} & -- & -- & -- & -- \\
 		\hline
 		141 & \texttt{HIGH OSMOLARITY AND MATING PATHWAYS} & 43 & 2 & 94 & \cite{bbm-141, biomodels} \\
 		\hline
 		142 & \texttt{BLOOD STEM CELL} & 27 & 2 & 126 & \cite{bbm-142, biomodels} \\
 		\hline
		143 & \texttt{----} & -- & -- & -- & -- \\
 		\hline
		144 & \texttt{----} & -- & -- & -- & -- \\
 		\hline
 		145 & \texttt{MELANOGENESIS} & 61 & 1 & 113 & \cite{bbm-145} \\
 		\hline
 		146 & \texttt{BUDDING YEAST FAURE 2009} & 40 & 10 & 271 & \cite{bbm-146-147-159-180, ginsim} \\
 		\hline
 		147 & \texttt{BUDDING YEAST EXIT MODULE} & 11 & 5 & 44 & \cite{bbm-146-147-159-180, ginsim} \\
 		\hline
 		148 & \texttt{AGS CELL FATE DECISION} & 83 & 0 & 185 & \cite{bbm-148-149, ginsim} \\
 		\hline
 		149 & \texttt{AGS CELL FATE DECISION REDUCED} & 12 & 2 & 62 & \cite{bbm-148-149, ginsim} \\
 		\hline
 		150 & \texttt{CELL FATE DECISION MULTISCALE} & 31 & 2 & 52 & \cite{bbm-008-150, ginsim} \\
 		\hline
 		151 & \texttt{TCR REDOX METABOLISM} & 130 & 3 & 417 & \cite{bbm-151-152, ginsim} \\
 		\hline
 		152 & \texttt{TCR REDOX METABOLISM REDUCED} & 50 & 3 & 288 & \cite{bbm-151-152, ginsim} \\
 		\hline
 		153 & \texttt{CONTROL OF PROLIFERATION} & 17 & 1 & 34 & \cite{bbm-153, ginsim} \\
 		\hline
 		154 & \texttt{CONTROL OF TH1 TH2 DIFFERENTIATION} & 18 & 3 & 50 & \cite{bbm-154, ginsim} \\
 		\hline
 		155 & \texttt{CONTROL OF TH1 TH2 TH17 TREG DIFFERENTATION} & 45 & 26 & 164 & \cite{bbm-155-156, ginsim} \\
 		\hline
 		156 & \texttt{CONTROL OF TH1 TH2 TH17 TREG DIFFERENTATION REDUCED} & 23 & 13 & 108 & \cite{bbm-155-156, ginsim} \\
 		\hline
 		157 & \texttt{CONTROL OF TH DIFFERENTATION} & 62 & 41 & 234 & \cite{bbm-157, ginsim} \\
 		\hline
 		158 & \texttt{LAMBDA PHAGE LYSOGENY} & 7 & 0 & 30 & \cite{bbm-158, ginsim} \\
 		\hline
 		159 & \texttt{BUDDING YEAST CORE} & 31 & 8 & 158 & \cite{bbm-146-147-159-180, ginsim} \\
 		\hline
 		160 & \texttt{IL17 DIFFERENTIAL EXPRESSION} & 76 & 16 & 246 & \cite{bbm-160, ginsim, biomodels} \\
 		\hline
 	\end{tabular}
 
	 \begin{tabular}{ | C{16pt} | C{149pt} | C{25pt} | C{25pt} | C{25pt} | C{35pt} | }
	 	\hline
	 	ID & Name & Vars. & Inps. & Regs. & Source \\ 	 	
	 	\hline
	 	161 & \texttt{DIFFERENTIATION OF MONOCYTES} & 94 & 2 & 244 & \cite{bbm-161, ginsim} \\
	 	\hline
	 	162 & \texttt{DROSOPHILA DPP PATHWAY} & 10 & 8 & 40 & \cite{bbm-drosophila, ginsim} \\
	 	\hline
	 	163 & \texttt{DROSOPHILA EGF PATHWAY} & 24 & 10 & 84 & \cite{bbm-drosophila, ginsim} \\
	 	\hline
	 	164 & \texttt{EGGSHELL PATTERNING MECHANISTIC} & 17 & 7 & 62 & \cite{bbm-164-165, ginsim} \\
	 	\hline
	 	165 & \texttt{EGGSHELL PATTERNING PHENOMOENOLOGICAL} & 4 & 4 & 16 & \cite{bbm-164-165, ginsim} \\
	 	\hline
	 	166 & \texttt{DROSOPHILA JAK STAT PATHWAY} & 7 & 12 & 36 & \cite{bbm-drosophila, ginsim} \\
	 	\hline
	 	167 & \texttt{MESODERM SPECIFICATION IN DROSOPHILA} & 41 & 16 & 130 & \cite{bbm-167, biomodels, ginsim} \\
	 	\hline
	 	168 & \texttt{DROSOPHILA NOTCH PATHWAY} & 7 & 6 & 26 & \cite{bbm-drosophila, ginsim} \\
	 	\hline
	 	169 & \texttt{DROSOPHILA GAP A} & 5 & 2 & 17 & \cite{bbm-169-170-171-172, ginsim} \\
	 	\hline
	 	170 & \texttt{DROSOPHILA GAP B} & 4 & 3 & 15 & \cite{bbm-169-170-171-172, ginsim} \\
	 	\hline
	 	171 & \texttt{DROSOPHILA GAP C} & 5 & 2 & 20 & \cite{bbm-169-170-171-172, ginsim} \\
	 	\hline
	 	172 & \texttt{DROSOPHILA GAP D} & 5 & 2 & 12 & \cite{bbm-169-170-171-172, ginsim} \\
	 	\hline
	 	173 & \texttt{----} & & & & \\
	 	\hline
	 	174 & \texttt{----} & & & & \\
	 	\hline
	 	175 & \texttt{SEA URCHIN} & 32 & 9 & 95 & \cite{bbm-175, ginsim, biomodels} \\
	 	\hline
	 	176 & \texttt{MYELOFIBROTIC MICROENVIRONMENT} & 47 & 2 & 148 & \cite{bbm-176, ginsim} \\
	 	\hline
	 	177 & \texttt{LYMPHOID CELL SPECIFICATION} & 31 & 3 & 96 & \cite{bbm-073-177, ginsim} \\
	 	\hline
	 	178 & \texttt{MAST CELL ACTIVATION} & 45 & 3 & 72 & \cite{bbm-178, ginsim} \\
	 	\hline
	 	179 & \texttt{MICROENVIRONMENT CONTROL} & 46 & 10 & 149 & \cite{bbm-179, ginsim} \\
	 	\hline
	 	180 & \texttt{MORPHOGENETIC CHECKPOINT} & 11 & 1 & 36 & \cite{bbm-146-147-159-180, ginsim} \\
	 	\hline
	 	181 & \texttt{MULTILEVEL CELL CYCLE} & 12 & 1 & 59 & \cite{bbm-181-182, ginsim} \\
	 	\hline
	 	182 & \texttt{BOOLEAN CELL CYCLE} & 12 & 2 & 59 & \cite{bbm-181-182, ginsim} \\
	 	\hline
	 	183 & \texttt{ALTERATIONS IN BLADDER} & 31 & 4 & 111 & \cite{bbm-183, ginsim} \\
	 	\hline
	 	184 & \texttt{P53 MDM2 NETWORK} & 5 & 1 & 15 & \cite{bbm-184, ginsim} \\
	 	\hline
	 	185 & \texttt{CHICKEN SEX DETERMINATION} & 12 & 3 & 34 & \cite{bbm-185-186, ginsim} \\
	 	\hline
	 	186 & \texttt{CHICKEN SEX DETERMINATION REDUCED} & 7 & 3 & 25 & \cite{bbm-185-186, ginsim} \\
	 	\hline
	 	187 & \texttt{MAMMAL SEX DETERMINATION 1 CELL} & 13 & 6 & 55 & \cite{bbm-187-188, ginsim} \\
	 	\hline
	 	188 & \texttt{MAMMAL SEX DETERMINATION 2 CELL} & 30 & 7 & 132 & \cite{bbm-187-188, ginsim} \\
	 	\hline
	 	189 & \texttt{TRP BIOSYNTHESIS} & 5 & 1 & 13 & \cite{bbm-189, ginsim} \\
	 	\hline
	 	190 & \texttt{BRAF TREATMENT RESPONSE} & 32 & 5 & 74 & \cite{bbm-190, ginsim} \\
	 	\hline
	 	191 & \texttt{SEGMENT POLARITY 1 CELL} & 17 & 2 & 55 & \cite{bbm-191-192, ginsim} \\
	 	\hline
	 	192 & \texttt{SEGMENT POLARITY 6 CELL} & 102 & 0 & 352 & \cite{bbm-191-192, ginsim} \\
	 	\hline
	 	193 & \texttt{SENESCENCE G1S CHECKPOINT} & 28 & 2 & 100 & \cite{bbm-193, ginsim} \\
	 	\hline
	\end{tabular}

	\begin{tabular}{ | C{16pt} | C{149pt} | C{25pt} | C{25pt} | C{25pt} | C{35pt} | }
		\hline
		ID & Name & Vars. & Inps. & Regs. & Source \\ 	 	
		\hline
	 	194 & \texttt{VULVAR PRECURSOR CELLS} & 78 & 28 & 236 & \cite{bbm-194, ginsim} \\
		\hline
	 	195 & \texttt{CTLA4 PD1 CHECKPOINT INHIBITORS} & 161 & 55 & 439 & \cite{bbm-195, ginsim} \\
		\hline
		196 & \texttt{T-LYMPHOCYTE SPECIFICATION} & 58 & 3 & 237 & \cite{bbm-196, ginsim, biomodels} \\
		\hline
		197 & \texttt{ANTERIOR POSTERIOR BOUNDARY} & 48 & 8 & 253 & \cite{bbm-197, ginsim} \\
		\hline
		198 & \texttt{PAIR RULE MODULE} & 11 & 0 & 48 & \cite{bbm-198, ginsim} \\
		\hline
		199 & \texttt{----} & -- & -- & -- & -- \\
		\hline	 	
		200 & \texttt{----} & -- & -- & -- & -- \\
		\hline	 			
	\end{tabular}

	\begin{tabular}{ | C{16pt} | C{149pt} | C{25pt} | C{25pt} | C{25pt} | C{35pt} | }
		\hline
		ID & Name & Vars. & Inps. & Regs. & Source \\ 	 	
		\hline
	\end{tabular}
\end{center}

\bibliographystyle{plain}
\bibliography{report}

\end{document}